Literature DB >> 32404338

Revisiting Filtration Fraction as an Index of the Risk of Hemofilter Clotting in Continuous Venovenous Hemofiltration.

Parta Hatamizadeh1, Ashita Tolwani2, Paul Palevsky3.   

Abstract

Keywords:  ICU nephrology; acute kidney injury; blood coagulation; circuit clotting; continuous renal replacement therapy; continuous venovenous hemofiltration; critical care medicine; critical care nephrology; extracorporeal circuit clotting; extracorporeal circuit malfunction; filtration fraction; renal replacement therapy; ultrafiltration

Year:  2020        PMID： 32404338      PMCID： PMC7646243          DOI： 10.2215/CJN.02410220

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  9 in total

1.  Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation.

Authors:  P H J van der Voort; R T Gerritsen; M A Kuiper; P H M Egbers; W P Kingma; E C Boerma
Journal:  Blood Purif       Date:  2005-02-10       Impact factor: 2.614

2.  Pre-dilution vs. post-dilution during continuous veno-venous hemofiltration: impact on filter life and azotemic control.

Authors:  Shigehiko Uchino; Nigel Fealy; Ian Baldwin; Hiroshi Morimatsu; Rinaldo Bellomo
Journal:  Nephron Clin Pract       Date:  2003

Review 3.  Continuous renal-replacement therapy for acute kidney injury.

Authors:  Ashita Tolwani
Journal:  N Engl J Med       Date:  2012-12-27       Impact factor: 91.245

4.  Management of anuric intensive-care patients with arteriovenous hemofiltration.

Authors:  P Kramer; G Kaufhold; H J Gröne; W Wigger; J Rieger; D Matthaei; T Stokke; H Burchardi; F Scheler
Journal:  Int J Artif Organs       Date:  1980-07       Impact factor: 1.595

5.  Effect of hematocrit on blood pressure via hyperviscosity.

Authors:  Y Cinar; G Demir; M Paç; A B Cinar
Journal:  Am J Hypertens       Date:  1999-07       Impact factor: 2.689

Review 6.  On-line hemodiafiltration: technique and efficiency.

Authors:  Luciano A Pedrini
Journal:  J Nephrol       Date:  2003 Nov-Dec       Impact factor: 3.902

7.  Continuous arteriovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics.

Authors:  A Lauer; A Saccaggi; C Ronco; M Belledonne; S Glabman; J P Bosch
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

8.  Circuit life versus bleeding risk: the impact of achieved activated partial thromboplastin time versus achieved filtration fraction.

Authors:  Clare MacEwen; Peter Watkinson; Christopher Winearls
Journal:  Ther Apher Dial       Date:  2014-12-16       Impact factor: 1.762

Review 9.  Nomenclature for renal replacement therapy in acute kidney injury: basic principles.

Authors:  Mauro Neri; Gianluca Villa; Francesco Garzotto; Sean Bagshaw; Rinaldo Bellomo; Jorge Cerda; Fiorenza Ferrari; Silvia Guggia; Michael Joannidis; John Kellum; Jeong Chul Kim; Ravindra L Mehta; Zaccaria Ricci; Alberto Trevisani; Silvio Marafon; William R Clark; Jean-Louis Vincent; Claudio Ronco
Journal:  Crit Care       Date:  2016-10-10       Impact factor: 9.097
  9 in total
  1 in total

Review 1.  Dose of Continuous Renal Replacement Therapy in Critically Ill Patients: A Bona Fide Quality Indicator.

Authors:  Enzo Vásquez Jiménez; Samaya J Anumudu; Javier A Neyra
Journal:  Nephron       Date:  2021-02-04       Impact factor: 2.847
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.